Conversely, Vodafone Idea's shares fell 3.85% after reporting a consolidated net loss of Rs 6,609.3 crore in Q3 FY25, despite a revenue rise of 4.16%.

Overall, the financial sector saw a slight increase of 0.45%, breaking a five-day losing streak amidst the downturn.

On February 13, 2025, the Nifty index fell below the 23,050 level, with the S&P BSE Sensex declining by 122.52 points (0.16%) to 76,171.08 and the Nifty 50 index losing 26.55 points (0.12%) to 23,045.25.

This marked the seventh consecutive day of losses for domestic equity benchmarks in India, driven by global uncertainties, particularly surrounding tariff wars.

Notably, Bharat Electronics, Adani Ports, and Adani Enterprises were among the largest drags on the market, with declines of 4.38%, 4.20%, and 4.12% respectively.

Corporate India's earnings growth remains sluggish, with combined net sales growing in single digits for the seventh straight quarter, and net profit also increasing by a single digit for the third consecutive quarter in Q3 FY25.

In a slight positive development, data released post-market hours indicated a drop in India’s retail inflation to 4.31%, providing some relief amid ongoing economic uncertainties.

Meanwhile, the India VIX, which measures market volatility, surged by 5.82% to 15.89, reflecting heightened investor caution.

The yield on India's 10-year benchmark federal paper rose to 6.811%, while the rupee depreciated slightly against the dollar, settling at 86.9050.

In global markets, mixed results were observed, with European markets advancing while U.S. major averages closed lower ahead of the Consumer Price Index report.

In the U.S., retail sales fell by 0.9% in January, indicating weakness, while the Dow Jones Industrial Average and S&P 500 also closed lower.

On a more positive note, Zydus Lifesciences' stock rose by 1.75% after a successful USFDA inspection of its API manufacturing facility in Ambernath, Maharashtra.